Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2237819

CC1=C([Zr+2](C2=C(C)Cc3cc4c(cc32)C(C)(C)CCC4(C)C)[SiH](c2ccccc2)c2ccccc2)c2cc3c(cc2C1)C(C)(C)CCC3(C)C.[Cl-].[Cl-]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 1/20 0.30
SLC6A2 known ✓ P23975 1/20 0.30
SLC6A3 known ✓ Q01959 1/20 0.30
RXRA P19793 12/20 0.38
RARB P10826 9/20 0.38
RARA P10276 9/20 0.38
RXRG P48443 8/20 0.38
RXRB P28702 8/20 0.38
RARG P13631 7/20 0.34
MEN1 O00255 1/20 0.30
CYP26A1 O43174 1/20 0.30
ABCB11 O95342 1/20 0.30
ESR1 P03372 1/20 0.30
PGR P06401 1/20 0.30
HTR1A P08908 1/20 0.30
ADRA2A P08913 1/20 0.30
ADORA3 P0DMS8 1/20 0.30
DRD1 P21728 1/20 0.30
TBXA2R P21731 1/20 0.30
ADRA1A P35348 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30062693 0.73 RXRA (0.38) RXRARARBRARARXRGRXRB
Hydrochloric Acid SCHEMBL15653289 0.65 RXRA (0.33) RXRARARBRARARXRGRXRB
SCHEMBL4409935 0.65 RXRA (0.34) RXRARARBRARARXRGRXRB
SCHEMBL5009416 0.65 RXRA (0.41) RXRARARBRARARXRGRXRB
SCHEMBL29401105 0.65 RXRA (0.41) RXRARARBRARARXRGRXRB
Lithium SCHEMBL29602414 0.63 RXRA (0.40) RXRARARBRARARXRGRXRB
Hydrochloric Acid SCHEMBL2237817 0.62 RXRA (0.33) RXRARARBRARARXRGRXRB
SCHEMBL6910159 0.62 RXRA (0.33) RXRARARBRARARXRGRXRB
SCHEMBL29970646 0.62 RARB (0.36) RXRARARBRARARXRGRXRB
SCHEMBL17911672 0.62 RARB (0.36) RXRARARBRARARXRGRXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9139794-B2 Process for the production of polymeric compositions useful as oil modifiers EXXONMOBIL CHEMICAL PATENTS INC. (US) 2015-09-22 US claimed
EP-2809716-A1 PROCESS FOR THE PRODUCTION OF POLYMERIC COMPOSITIONS USEFUL AS OIL MODIFIERS ExxonMobil Chemical Patents Inc. (US) 2014-12-10 EP claimed
US-20130203641-A1 Process for the Production of Polymeric Compositions Useful as Oil Modifiers EXXONMOBIL CHEMICAL PATENTS INC. 2013-08-08 US claimed
WO-2013115912-A1 PROCESS FOR THE PRODUCTION OF POLYMERIC COMPOSITIONS USEFUL AS OIL MODIFIERS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2013-08-08 WO claimed
US-20130143461-A1 Polymer Compositions and Nonwoven Compositions Prepared Therefrom EXXONMOBIL CHEMICAL PATENTS INC. 2013-06-06 US claimed
US-12529167-B2 Bicomponent polymeric fibers EXXONMOBIL CHEMICAL PATENTS INC. (US) 2026-01-20 US disclosed
US-20230332335-A1 Bicomponent Polymeric Fibers EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-10-19 US disclosed
US-11549201-B2 Fibers and nonwoven materials prepared therefrom EXXONMOBIL CHEMICALS PATENTS INC. (US) 2023-01-10 US disclosed
US-11525041-B2 Process for producing polymers EXXONMOBIL CHEMICALS PATENTS INC. (US) 2022-12-13 US disclosed
US-11492477-B2 Polymer compositions and nonwoven compositions prepared therefrom EXXONMOBIL CHEMICALS PATENT INC. (US) 2022-11-08 US disclosed
US-11214036-B2 Fibers and nonwoven materials prepared therefrom EXXONMOBIL CHEMICAL PATENTS INC. (US) 2022-01-04 US disclosed
EP-3004241-B1 POLYMER COMPOSITIONS AND NONWOVEN COMPOSITIONS PREPARED THEREFROM EXXONMOBIL CHEMICAL PATENTS INC (US) 2021-08-11 EP disclosed
US-20120123374-A1 Meltblown Nonwoven Compositions and Methods for Making Them EXXONMOBIL CHEMICAL PATENTS INC. 2012-05-17 US disclosed
WO-2011102946-A1 ELASTOMERIC POLYMER BLENDS AND PROCESSES FOR THEIR PRODUCTION EXXONMOBIL CHEMICAL PARENTS INC. (US) 2011-08-25 WO disclosed
US-20110207888-A1 Elastomeric Polymer Blends and Processes for Their Production EXXONMOBIL CHEMICAL PATENTS INC. 2011-08-25 US disclosed
US-7601666-B2 Provide polymers having high molecular weight as well as good crystallinity preferably prepared at higher temperatures and productivities than otherwise possible EXXONMOBIL CHEMICAL PATENTS INC. (US) 2009-10-13 US disclosed
EP-1765841-B1 OLEFIN POLYMERIZATION CATALYST SYSTEM AND PROCESS FOR USE THEREOF EXXONMOBIL CHEM PATENTS INC (US) 2008-10-08 EP disclosed
EP-1765841-A2 OLEFIN POLYMERIZATION CATALYST SYSTEM AND PROCESS FOR USE THEREOF Exxonmobil Chemical Patents Inc. (US) 2007-03-28 EP disclosed
WO-2006010139-A2 OLEFIN POLYMERIZATION CATALYST SYSTEM AND PROCESS FOR USE THEREOF EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-01-26 WO disclosed
US-20060009595-A1 Olefin polymerization catalyst system and process for use thereof EXXONMOBIL CHEMICAL PATENTS INC. 2006-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060009595-A1 Olefin polymerization catalyst system and process for use thereof OR10J3, CHRM2, CHRM1 CHRM1 3/4885SLC6A2 4188/4885SLC6A3 4327/4885
US-12529167-B2 Bicomponent polymeric fibers MST1, COPE, MSTN CHRM1 844/4885SLC6A2 4790/4885SLC6A3 4834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.